Latest News
Initial Hepatitis C drug trial complete

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.
Completion of the initial phase (phase 1a) of trials of INX-189, discovered and first prepared by researchers at Cardiff University’s Welsh School of Pharmacy in 2008, means the chances of it becoming an approved medicine have significantly improved.
Approximately 170 million people worldwide are affected with Hepatitis C, which can lead to liver cancer, cirrhosis and death. It is the leading cause of liver transplantation in western countries. The current treatment involves two drugs – ribavirin and interferon, which has to be given as an injection. Side effects are often severe and lead to patients failing to complete the treatment.
27/08/2010
Leaders in entrepreneurship gather at Cardiff University
Focus On
How the University and its Schools are working towards a more sustainable planet
Main Building, one of the University's most impressive pieces of architecture, celebrated its centenary on 14th October 2009.

